Ortin Global Limited (NSE:ORTINGLOBE)
14.75
-0.35 (-2.32%)
Sep 24, 2026, 3:10 PM IST
Ortin Global Market Cap
Ortin Global has a market cap or net worth of 124.41 million as of September 23, 2026. Its market cap has increased by 27.93% in one year.
Market Cap
124.41M
Enterprise Value
128.40M
Revenue
356.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.75
ChartMarket Cap Chart
Since April 12, 2007, Ortin Global's market cap has increased from 48.26M to 124.41M, an increase of 157.80%. That is a compound annual growth rate of 4.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 124.41M | 7.14% |
| Dec 31, 2025 | 116.12M | -20.22% |
| Dec 31, 2024 | 145.55M | -22.24% |
| Dec 29, 2023 | 187.18M | -2.87% |
| Dec 30, 2022 | 192.71M | -27.96% |
| Dec 31, 2021 | 267.52M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 7.65B |
| Amanta Healthcare | 7.38B |
| Valiant Laboratories | 6.69B |
| Nectar Lifesciences | 2.13B |
| Brooks Laboratories | 1.81B |
| Par Drugs and Chemicals | 1.68B |
| Balaxi Pharmaceuticals | 1.30B |
| Alpa Laboratories | 1.25B |